HEALTH

  • 563
  • 536

UK cancer patient joins trial for world's first skin cancer vaccine - ETHealthWorld

​The new Phase 3 clinical trial, being led by UCLH, is evaluating the combination of mRNA-4157 (V940) and Keytruda (pembrolizumab) versus a current standard of care (pembrolizumab) as a risk-reducing treatment option for patients with resected high-risk, stag…

image

Ads

Video News

Hot News

Ads

News Letter

Your email address will not be this published. Required fields are News Today.